Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2018
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic CancerAdam J Camblin, Emily A Pace, Sharlene Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma TherapyMyrthala Moreno-Smith, Anna Lakoma, Zaowen Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic CancerZev A Wainberg, Howard S Hochster, Edward J Kim, et al.
Cancer Letters|July 1, 2015
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastomaAnneleen Beckers, Gert Van Peer, Daniel R Carter, et al.
Molecular Cancer Therapeutics|March 26, 2026
Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk NeuroblastomaGriffin I Kane, Miranda B Diaz-Infante, Kim Wigglesworth, et al.
Oncotarget|December 8, 2017
EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastomaWenjing Sun, Yesenia Rojas, Hao Wang, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Ejhaem|July 18, 2022
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease RegistryDaniel A Pollyea, Tracy I George, Mehrdad Abedi, et al.
Transplantation and Cellular Therapy|April 22, 2023
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to CareBenjamin Tomlinson, Marcos de Lima, Christopher R Cogle, et al.
International Journal of Laboratory Hematology|November 21, 2020
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromesJay L Patel, Mehrdad Abedi, Christopher R Cogle, et al.
Pageof 8